Oxygen Monitoring for Pharmaceutical Reactor Inerting

Continuous Atmosphere Verification for Oxidation-Sensitive Pharmaceutical Reactions OMD-525X

Pharmaceutical reactors handling oxidation-sensitive intermediates or solvent-based reactions are commonly inerted with nitrogen to protect product quality and eliminate the risk of a flammable atmosphere forming from solvent vapors. Confirming and documenting reactor headspace oxygen levels is a standard part of process safety and quality control in pharmaceutical manufacturing.

The OMD-525X gives pharmaceutical manufacturers continuous, reliable oxygen monitoring on reactor systems, supporting both process safety and the documented atmosphere control that GMP manufacturing requires.

Why Reactor Inerting Verification Matters

Oxidation-sensitive pharmaceutical reactions can be compromised by oxygen ingress into the reactor headspace, while solvent-laden atmospheres carry a separate flammability risk if inerting is inadequate. Continuous oxygen monitoring on the reactor confirms the atmosphere remains within validated limits throughout the reaction and provides the documented record that pharmaceutical quality and safety systems require.

Where It's Used

  • Batch reactor headspace monitoring verifying atmosphere throughout the reaction cycle
  • Solvent-based reaction inerting supporting flammability risk reduction
  • Reactor charging and discharging confirming safe atmosphere during material transfer
  • Process validation and batch documentation recording atmosphere conditions for quality records

Recommended Analyzer

The OMD-525X provides stable, continuous trace oxygen measurement suited to the documented process control that pharmaceutical reactor inerting requires.

With reliable analog and digital outputs, the OMD-525X integrates into reactor control systems and facility data logging to support process validation and batch record requirements.

Spécifications principales

Foire aux questions

Trace oxygen measurement provides a direct indication of oxygen contamination or crossover into the hydrogen stream. Trending the oxygen concentration can help operators identify changes in electrolyser or purification system performance.

A common measurement point is the hydrogen product stream downstream of the electrolyser stack. Additional measurement points may be used before or after drying and purification equipment depending on the process design and monitoring objectives.

Alarm and control limits should be determined based on the electrolyser manufacturer’s specifications, process conditions, applicable standards, and the facility’s safety requirements rather than using a universal oxygen alarm value.

NEED HELP SPECIFYING AN ANALYZER FOR YOUR OPERATION?

Our application engineers can help confirm the right model for your process conditions.